-
1101por Abebe, Tamrat, Takele, Yegnasew, Weldegebreal, Teklu, Cloke, Tom, Closs, Ellen, Corset, Camille, Hailu, Asrat, Hailu, Workagegnehu, Sisay, Yifru, Corware, Karina, Corset, Margaux, Modolell, Manuel, Munder, Markus, Tacchini-Cottier, Fabienne, Müller, Ingrid, Kropf, Pascale“…The underlying mechanisms resulting in the profound immune suppression characteristic of human visceral leishmaniasis (VL) are not fully understood. Here, we tested the hypothesis that arginase, an enzyme associated with immunosuppression, is higher in patients with VL and contributes to impaired T cell responses. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1102por Alasaad, SamerEnlace del recurso
Publicado 2013
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1103por Belo, Vinícius Silva, Werneck, Guilherme Loureiro, Barbosa, David Soeiro, Simões, Taynãna César, Nascimento, Bruno Warlley Leandro, da Silva, Eduardo Sérgio, Struchiner, Claudio José“…BACKGROUND: Still today, more than 30 years after the beginning of the process of visceral leishmaniasis' urbanization, there is little knowledge about the risk factors for its occurrence, despite their relevance to the control and understanding of disease dynamics. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1104por Topuzogullari, Murat, Cakir Koc, Rabia, Dincer Isoglu, Sevil, Bagirova, Melahat, Akdeste, Zeynep, Elcicek, Serhat, Oztel, Olga N, Yesilkir Baydar, Serap, Canim Ates, Sezen, Allahverdiyev, Adil M“…Therefore, we aimed to develop a potential vaccine candidate against leishmaniasis by covalently conjugating PAA with an immunologically vital molecule of lipophosphoglycan (LPG) found in Leishmania parasites. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1105por Domingos, Patrícia Luciana Batista, Viana, Agostinho Gonçalves, Fraga, Carlos Alberto de Carvalho, Bonan, Paulo Rogério Ferreti“…METHODS: The tissue samples were collected from indolent skin ulcers confirmed as cutaneous leishmaniasis of 41 patients aged between six and 90 years. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1106por Viana, Agostinho Gonçalves, Mayrink, Wilson, Fraga, Carlos Alberto de Carvalho, Silva, Luciana Maria, Domingos, Patrícia Luciana Batista, Bonan, Paulo Rogério Ferreti, de Paula, Alfredo Maurício Batista, Botelho, Ana Cristina de Carvalho“…BACKGROUND: The histopathology and immune responses of the healing process of leishmaniasis are still poorly studied. OBJECTIVES: This study aimed to examine the histopathological and immunological aspects of lesions of patients with cutaneous leishmaniasis before and after different therapeutic methods. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1107Estimating the Optimal Control of Zoonotic Visceral Leishmaniasis by the Use of a Mathematical Model“…We argue that the strategy of culling infected dogs is not the most efficient way to control zoonotic visceral leishmaniasis (ZVL) and that, in the presence of alternative control strategies with better potential results, official programs of compulsory culling adopted by some countries are inefficient and unethical. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1108por Argaw, Daniel, Mulugeta, Abate, Herrero, Mercè, Nombela, Nohelly, Teklu, Tsegemariam, Tefera, Teodros, Belew, Zewdu, Alvar, Jorge, Bern, Caryn“…BACKGROUND: Visceral leishmaniasis is a lethal parasitic disease transmitted by phlebotomine sand flies. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1109por de Araújo, Valdelaine Etelvina Miranda, Pinheiro, Letícia Cavalari, Almeida, Maria Cristina de Mattos, de Menezes, Fernanda Carvalho, Morais, Maria Helena Franco, Reis, Ilka Afonso, Assunção, Renato Martins, Carneiro, Mariângela“…BACKGROUND: Visceral leishmaniasis (VL) is a vector-borne disease whose factors involved in transmission are poorly understood, especially in more urban and densely populated counties. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1110por Yaghoobi-Ershadi, Mohammad Reza, Shahbazi, Farideh, Darvishi, Mohammad, Akhavan, Amir Ahmad, Jafari, Reza, Khajeian, Mohammad, Rassi, Yavar, Soleimani, Hassan, Shirzadi, Mohammad Reza, Hanafi-Bojd, Ahmad Ali, Darabi, Hossein, Arandian, Mohammad Hossein, Sanei-Dehkordi, Alireza, Heidari, Mansour“…BACKGROUND: Cutaneous leishmaniasis (CL) represents the most frequent vector borne parasitoses in Iran. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1111por Picado, Albert, Ostyn, Bart, Singh, Shri Prakash, Uranw, Surendra, Hasker, Epco, Rijal, Suman, Sundar, Shyam, Boelaert, Marleen, Chappuis, François“…There is increasing interest in the role of asymptomatic infection in transmission of Visceral Leishmaniasis (VL). We studied the individual, household and environmental factors associated with asymptomatic Leishmania donovani infected individuals and VL. 7,538 individuals living in VL endemic villages in India and Nepal were divided into three mutually exclusive groups based on their VL history and Direct Agglutination Test (DAT) results in yearly serosurveys over a two-year period. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1112por Pereira, Mariana R., Rocha-Silva, Fabiana, Graciele-Melo, Cidiane, Lafuente, Camila R., Magalhães, Telcia, Caligiorne, Rachel B.“…The diagnosis of visceral leishmaniasis (VL) is a challenging issue and several studies worldwide have evaluated the different tools to reach a diagnostic solution. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1113por Wondimeneh, Yitayih, Takele, Yegnasew, Atnafu, Asmamaw, Ferede, Getachew, Muluye, Dagnachew“…Background. Visceral leishmaniasis (VL) is a systemic disease caused by the Leishmania donovani complex. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1114por Kumar, Dinesh, Tiwary, Puja, Dube, Anuradha, Chakravarty, Jaya, Rai, Madhukar, Sundar, Shyam“…BACKGROUND: Rapid diagnostic test using rk39 antigen is widely used for visceral leishmaniasis. However it detects anti-rk39 antibodies in 20-32% of endemic healthy individuals. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1115“…Visceral leishmaniasis (VL) (kala-azar) was most seriously prevalent in the plain regions of eight provinces/municipalities in the eastern and central parts of China. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1116por van den Bogaart, Erika, Talha, Al-Badawi A, Straetemans, Masja, Mens, Pètra F, Adams, Emily R, Grobusch, Martin P, Nour, Bakri Y M, Schallig, Henk D F H“…Its ability to mediate the interplay between visceral leishmaniasis (VL) and malaria has been suggested, but poorly documented. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1117por Das, Vidya Nand Ravi, Pandey, Ravindra Nath, Pandey, Krishna, Singh, Varsha, Kumar, Vijay, Matlashewski, Greg, Das, Pradeep“…BACKGROUND: One of the major challenges for management of visceral leishmaniasis (VL) is early diagnosis of cases to improve treatment outcome and reduce transmission. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1118por Ostyn, Bart, Hasker, Epco, Dorlo, Thomas P. C., Rijal, Suman, Sundar, Shyam, Dujardin, Jean-Claude, Boelaert, Marleen“…BACKGROUND: High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in India and Nepal followed up for twelve months. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1119por Khouri, Ricardo, Santos, Gilvaneia Silva, Soares, George, Costa, Jackson M., Barral, Aldina, Barral-Netto, Manoel, Van Weyenbergh, Johan“…We show that increased plasma superoxide dismutase 1 (SOD1) levels are statistically significant predictors of the failure of pentavalent antimony treatment for cutaneous leishmaniasis caused by Leishmania braziliensis. In Leishmania amazonensis–infected patients, host SOD1 levels can be used to discriminate between localized and drug-resistant diffuse cutaneous leishmaniasis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1120